Cargando…

Does dose-dense neoadjuvant chemotherapy have clinically significant prognostic value in breast cancer?: A meta-analysis of 3,724 patients

PURPOSE: Neoadjuvant chemotherapy (NCT) is typically the initial treatment for non-early breast cancer patients. We thereby conducted a meta-analysis to explore whether dose-dense neoadjuvant chemotherapy (ddNCT) improved the long-term prognosis of patients compared to the standard NCT regimen. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Yuqin, Ding, Kaijing, Yang, Hongjian, He, Xiangming, Mo, Wenju, Ding, Xiaowen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259732/ https://www.ncbi.nlm.nih.gov/pubmed/32470093 http://dx.doi.org/10.1371/journal.pone.0234058

Ejemplares similares

Prognosis and endocrine therapy selection for patients with low hormone receptor-positive breast cancer following neoadjuvant chemotherapy: A retrospective study of 570 patients in China
por: Ding, Yuqin, et al.
Publicado: (2019)

Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer
por: Ding, Yuqin, et al.
Publicado: (2020)

The Value of Neoadjuvant Anthracycline-Based Regimens for HER2-Positive Breast Cancer: A Systematic Review and Meta-analysis Including 1366 Patients
por: Ding, Yuqin, et al.
Publicado: (2023)

CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy
por: Tong, Yilin, et al.
Publicado: (2021)

Study of lncRNA TPA in Promoting Invasion and Metastasis of Breast Cancer Mediated by TGF-β Signaling Pathway
por: Li, Qinglin, et al.
Publicado: (2021)

CA724 Predicts Tumor Regression Grade in Locally Advanced Gastric Cancer Patients with Neoadjuvant Chemotherapy
por: Tong, Yilin, et al.
Publicado: (2021)

NMR-Based Metabolomics Analysis Predicts Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
por: He, Xiangming, et al.
Publicado: (2021)

LncRNA TDRKH-AS1 promotes breast cancer progression via the miR-134-5p/CREB1 axis
por: Ding, Yuqin, et al.
Publicado: (2023)

Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis
por: Mo, Wenju, et al.
Publicado: (2020)

Long non-coding RNAs may serve as biomarkers in breast cancer combined with primary lung cancer
por: Ding, Xianfeng, et al.
Publicado: (2017)

Study on the Differential Value of Tumor Marker CA724 on Primary Gastric Cancer
por: Ding, Jieying, et al.
Publicado: (2021)

The CD20-specific engineered toxin antibody MT-3724 exhibits lethal effects against mantle cell lymphoma
por: Huang, Shengjian, et al.
Publicado: (2018)

Pneumocystis jirovecii Pneumonia in a Patient with Breast Cancer Receiving Neoadjuvant Dose-dense Chemotherapy
por: Watanabe, Hirofumi, et al.
Publicado: (2019)

Pneumocystis jirovecii Pneumonia in Three Patients With Breast Cancer Receiving Neoadjuvant Dose-Dense Chemotherapy
por: Shiiba, Ritsuya, et al.
Publicado: (2022)

Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell Lymphoma
por: Hamlin, Paul A., et al.
Publicado: (2022)

EFFECTS OF SALVIA MILTIORRHIZAE ON THE KIDNEY OF RATS WITH SEVERE ACUTE PANCREATITIS AND OBSTRUTIVE JAUNDICE
por: Guibing, Ren, et al.
Publicado: (2017)

Comparative hematological profiles for dose-dense vs. regular anthracycline-based neoadjuvant chemotherapy in non-metastatic breast cancer
por: Popovici, Dorel, et al.
Publicado: (2021)

Determination of serum CA724 levels using fluorescence immunochromatography
por: Liu, Chang, et al.
Publicado: (2023)

Serum CA724 has no diagnostic value for gastrointestinal tumors
por: Cao, Huiru, et al.
Publicado: (2023)

Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations
por: Cocciolone, Valentina, et al.
Publicado: (2018)

Genome-Wide Identification, Characterization and Expression Analysis of the TaDUF724 Gene Family in Wheat (Triticum aestivum)
por: Yuan, Yi, et al.
Publicado: (2023)

Effects of neoadjuvant chemotherapy on respiratory function in patients with breast cancer
por: Ding, Lei, et al.
Publicado: (2020)

Impact of dose-dense neoadjuvant chemotherapy on pathologic response and survival for HER2-positive breast cancer patients who receive trastuzumab
por: Wang, Lize, et al.
Publicado: (2021)

Nab-paclitaxel Followed by Dose-dense Epirubicin/Cyclophosphamide in Neoadjuvant Chemotherapy for Triple-negative Breast Cancer: A Phase II Study
por: Liu, Yin, et al.
Publicado: (2022)

Dose-dense adjuvant chemotherapy for primary breast cancer
por: Fornier, Monica, et al.
Publicado: (2005)

Efficacy and safety of dose-dense chemotherapy in urothelial carcinoma
por: Zhu, Chenjing, et al.
Publicado: (2017)

PB.37. Does conventional imaging accurately predict the extent of disease in women with dense breasts? If so, does this have a significant impact on patient surgical outcome?
por: Scott, V, et al.
Publicado: (2014)

PT724. Prevalence and Factors related to Medication Adherence in Chronic Psychiatric Disorder
por: Ihm, H.K., et al.
Publicado: (2016)

Spatial distribution characteristics of tumor marker CA724 reference values in China
por: Jing, Jing, et al.
Publicado: (2019)

724. The In Vitro Activity of Gepotidacin and Comparator Agents Against Anaerobic Bacterial Isolates
por: Hackel, Meredith, et al.
Publicado: (2019)

SAT-724 Endocrine Disruption by Phthalate Exposure in the Pediatric Intensive Care Unit
por: Jacobs, An, et al.
Publicado: (2020)

Afatinib as a Potential Therapeutic Option for Patients With NSCLC With EGFR G724S
por: Wei, Yang, et al.
Publicado: (2021)

Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer
por: Ding, Feng, et al.
Publicado: (2022)

Does chemotherapy regimen matter in the neoadjuvant treatment of esophageal cancer?
por: Logarajah, Shankar, et al.
Publicado: (2022)

Machine Learning-Based Radiomics Nomogram Using Magnetic Resonance Images for Prediction of Neoadjuvant Chemotherapy Efficacy in Breast Cancer Patients
por: Chen, Shujun, et al.
Publicado: (2020)

Clinical benefit and tolerability of adjuvant intraperitoneal chemotherapy in patients who have or have not received neoadjuvant chemotherapy for advanced ovarian cancer
por: Meghal, Trishala, et al.
Publicado: (2019)

Dose-dense chemotherapy for breast cancer: the story so far
por: Hudis, C
Publicado: (2000)

Measurement of molecular biomarkers that predict the tumor response in estrogen receptor-positive breast cancers after dose-dense (biweekly) paclitaxel/carboplatin neoadjuvant chemotherapy
por: Zhu, Teng, et al.
Publicado: (2017)

Neoadjuvant chemotherapy with dose dense MVAC is associated with improved survival after radical cystectomy compared to other cytotoxic regimens: A tertiary center experience
por: Lemiński, Artur, et al.
Publicado: (2021)

Neoadjuvant chemotherapy does not improve the prognosis and lymph node metastasis rate of locally advanced cervical squamous cell carcinoma: A retrospective cohort study in China
por: Yan, Wenxing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ao28e14r9k6ktjnni628rmrrkl